OraSure Technologies, Inc. OSUR
Set alert
As of Nov 2, 11:18 AM ET
- YTD
- +55.83%
- 1 year
- +37.64%
- Open
- 3.94
- Prev close
- 3.94
- Mkt cap
- 260.12M
- Vol
- 243.68K
- Avg vol
- 560.18K
- EPS
- -0.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.77
- High
- 4.00
- Forward P/E
- -22.63
- Beta
- 0.05
- Short ratio
- 1.91
- Inst. own
- 91.53%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.00
- 200-d avg
- 4.64
- 1y target
- 6.00
5D chart
Signals (74)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:45 PM | 2 days ago |
| RSI: Oversold | Oct 30, 12:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:55 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:45 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:55 PM | 3 days ago |
| RSI: Oversold | Oct 29, 3:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:00 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:05 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:10 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:40 AM | 5 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:30 PM | 5 days ago |
| RSI: Oversold | Oct 27, 2:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:40 PM | 5 days ago |
| RSI: Oversold | Oct 27, 1:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:05 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 11:15 AM | 6 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:45 AM | 6 days ago |
| SMA: Bearish | Oct 27, 10:35 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 6 days ago |
| SMA: Bullish | Oct 27, 9:55 AM | 6 days ago |
| MACD: Buy Signal | Oct 27, 9:50 AM | 6 days ago |
| MACD: Sell Signal | Oct 27, 9:40 AM | 6 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 6 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 6 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 6 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 6 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
| RSI: Oversold | Oct 26, 3:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:20 PM | 6 days ago |
| RSI: Overbought | Oct 26, 11:15 AM | 1 week ago |
News
6 hours ago globenewswire.com
OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care
Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation Collaboration will bring diagnostics expertise to a…
6 days ago globenewswire.com
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
BETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026,…
2 weeks ago defenseworld.net
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average – Here’s Why
OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $3.71 and traded as high as…
3 weeks ago defenseworld.net
Contrasting Establishment Labs (NASDAQ:ESTA) & OraSure Technologies (NASDAQ:OSUR)
Establishment Labs (NASDAQ: ESTA - Get Free Report) and OraSure Technologies (NASDAQ: OSUR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
3 weeks ago defenseworld.net
OraSure Technologies (NASDAQ:OSUR) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened
Shares of OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $3.68 and traded as…
1 month ago defenseworld.net
Head to Head Review: OraSure Technologies (NASDAQ:OSUR) and Profusa (NASDAQ:PFSA)
Profusa (NASDAQ: PFSA - Get Free Report) and OraSure Technologies (NASDAQ: OSUR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two…
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT)…
-
2 months ago benzinga.com
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report
2 months ago seekingalpha.com
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
OraSure Technologies Q2 Earnings Call Highlights
OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth…
-
2 months ago benzinga.com
OraSure Technologies Sees Q3 Sales $29.500M-$32.500M vs $31.143M Est
OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $29.500 million-$32.500 million vs $31.143 million analyst estimate.
2 months ago globenewswire.com
OraSure Announces Second Quarter 2026 Financial Results
BETHLEHEM, Pa. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its…
3 months ago globenewswire.com
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026,…
-
3 months ago benzinga.com
OraSure Technologies Receives FDA's Emergency Use Authorization For Its OraQuick Ebola 2.0 Rapid Antigen Test
OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has received Emergency Use…
3 months ago globenewswire.com
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic individuals and deceased patients. The rapid test detects the…
4 months ago globenewswire.com
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today…
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
5 months ago seekingalpha.com
OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
OraSure Technologies Sees Q2 Sales $27.000M-$30.000M vs $29.098M Est
OraSure Technologies (NASDAQ:OSUR) sees Q2 sales of $27.000 million-$30.000 million vs $29.098 million analyst estimate.
-
5 months ago benzinga.com
OraSure Technologies Q1 Adj. EPS $(0.24) Misses $(0.23) Estimate, Sales $27.925M Beat $27.707M Estimate
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 33.33 percent decrease over losses…
5 months ago globenewswire.com
OraSure Announces First Quarter 2026 Financial Results
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its…
6 months ago globenewswire.com
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and…
6 months ago globenewswire.com
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure…
6 months ago defenseworld.net
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why
OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $2.77 and…
7 months ago defenseworld.net
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
Shares of OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $2.78 and traded as…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
7 months ago benzinga.com
Altai Capital Presses OraSure Board For Overhaul, Nominates Two Directors
Altai Capital urges board changes at OraSure, citing underperformance, governance concerns, and misaligned CEO compensation.
-
7 months ago benzinga.com
OraSure Defends Strategy Amid Altai Proxy Push; Highlights 2026 Regulatory, Commercial Milestones And Shareholder Value Initiatives
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026Highlights Extensive Engagement with AltaiAltai Has Rejected All…
7 months ago globenewswire.com
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected…
-
7 months ago benzinga.com
'Altai Vows To Press On With Proxy Fight If Orasure Does Not Offer Board Seats; Investor Altai Capital Calls On Orasure Technologies To Put Itself Up For Sale, Letter Says' - Reuters Exclusive
Altai says OraSure is worth more sold than operating as a standalone companyAltai pressing for board seats after nominating two directors in JanuaryAltai says board failed to prevent missteps, pushes…
-
8 months ago benzinga.com
OraSure Technologies Sees Q1 Sales $26.000M-$29.000M vs $28.599M Est
OraSure Technologies (NASDAQ:OSUR) sees Q1 sales of $26.000 million-$29.000 million vs $28.599 million analyst estimate.
8 months ago benzinga.com
OraSure Technologies: Q4 Earnings Insights
OraSure Technologies: Q4 Earnings Insights
-
8 months ago benzinga.com
OraSure Technologies Q4 Adj. EPS $(0.19) Beats $(0.20) Estimate, Sales $26.763M Beat $26.443M Estimate
OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 7.32 percent. This is a 216.67 percent decrease over losses…
-
8 months ago benzinga.com
Earnings Scheduled For February 25, 2026
Earnings Scheduled For February 25, 2026
-
8 months ago benzinga.com
OraSure Technologies Announced Its OraQuick HIV Self-Test Has Received License From Health Canada
The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada's first oral HIV self-test and detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV…
-
10 months ago benzinga.com
OraSure Submits Two Separate Applications At 2025 End To FDA For Clearance Of Rapid Molecular Self-Test For CT/NG As Well As Colli-Pee At-Home Urine Collection Device For STIs
OraSure Technologies, Inc. (NASDAQ:OSUR) ("OraSure" and "OTI"), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate…
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
-
1 year ago benzinga.com
Earnings Scheduled For February 25, 2025
Earnings Scheduled For February 25, 2025
-
2 years ago benzinga.com
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
-
2 years ago benzinga.com
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
-
3 years ago benzinga.com
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
-
3 years ago benzinga.com
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
-
3 years ago benzinga.com
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
-
3 years ago benzinga.com
Earnings Scheduled For May 10, 2023
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
-
3 years ago benzinga.com
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
-
3 years ago benzinga.com
Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session.